Innosphere Engineering Ltd is pleased to announce the launch of recruitment for a randomized, sham-controlled, double-blind clinical trial examining the safety and effectiveness of Novostim 2 transcranial Random Noise Stimulation on ADHD symptoms in pediatric patients.

Paragon 28, Inc. announced that Albert DaCosta, Chairman and CEO, and Krissy Wright, Interim CFO, will participate in a fireside chat at the Bank of America Securities 2024 Healthcare Conference on Tuesday, May 14, 2024, at 5:00 p.m. Pacific Time / 6:00 p.m. Mountain Time.

Elutia Inc., a company pioneering drug-eluting biomatrix products, announced that it will release its first quarter 2024 financial results after market close on Thursday, May 9, 2024.

Anaut Inc., a pioneering developer in surgical support software led by CEO Dr. Nao Kobayashi, announced regulatory approval of its groundbreaking medical device, "Eureka α".

Senseonics Holdings, Inc. announced plans to participate in the upcoming RBC Capital Markets Global Healthcare Conference and the H.C. Wainwright 2nd Annual BioConnect Investor Conference, being held in New York, NY.

InMode Ltd., a leading global provider of innovative medical technologies, announced its consolidated financial results for the first quarter ended March 31, 2024.